Home › Asset managers › Compare 2023-2024 › Charles Schwab vs JPMorgan
Charles Schwab 2023-2024 · JPMorgan 2023-2024 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 3,936 | 3,482 | 333 | 121 | 91.3% | 90.4% |
| Board proposals | 3,140 | 2,933 | 137 | 70 | 95.5% | 94.6% |
| E&S shareholder proposals | 217 | 148 | 27 | 42 | 84.6% | 84.2% |
| Other items | 579 | 401 | 169 | 9 | 70.4% | 70.1% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
207 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Charles Schwab | JPMorgan |
|---|---|---|---|---|---|---|
| ADT INC. | May 22, 2024 | Approval of an amendment to the omnibus incentive plan to increase the number of shares of common stock authorized for issuance thereunder and extend the term Compensation |
Board | For | FOR 13 funds |
AGAINST 3 funds |
| AGENUS INC. | June 11, 2024 | To approve, in a non-binding advisory vote, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| AKOUSTIS TECHNOLOGIES INC. | November 2, 2023 | Proposal to approve, on a non-binding, advisory basis, the compensation paid to our named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| AMBARELLA INC. | June 12, 2024 | To approve an amendment and restatement of the Ambarella, Inc. 2021 Equity Incentive Plan. Compensation |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| AMERICAN AIRLINES GROUP INC. | June 5, 2024 | Advisory vote to approve executive compensation (Say-on-Pay) Say-on-Pay |
Board | For | FOR 16 funds |
AGAINST 7 funds |
| ANAPTYSBIO INC. | June 12, 2024 | To conduct a non-binding advisory vote on the compensation of our named executive officers as disclosed in the accompanying materials. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| ANGEL OAK MORTGAGE REIT INC. | May 15, 2024 | To approve, on a non-binding advisory basis, a resolution regarding the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | June 14, 2024 | To approve an amendment to the Amended and Restated 2019 Omnibus Equity Incentive Plan (as amended, the "Plan") to, among other things, increase the maximum number of shares of common stock available to Plan participants thereunder by 2,000,000 shares to an aggregate of 10,750,000 shares, as provided in Proposal Number 2 of the Proxy Statement. Compensation |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| ARIS WATER SOLUTIONS INC. | May 9, 2024 | Amend the Aris Water Solutions, Inc. 2021 Equity Incentive Plan to increase the number of shares of common stock that may be issued under the plan. Compensation |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| ARKO CORP. | June 6, 2024 | Amend the ARKO Corp. 2020 Incentive Compensation Plan to increase the number of shares of the Company's common stock, par value $0.0001 per share, available for awards thereunder. Compensation |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| ATARA BIOTHERAPEUTICS INC. | June 10, 2024 | To approve an automatic annual increase to the Company's 2024 Equity Incentive Plan. Compensation |
Board | For | AGAINST 3 funds |
FOR 2 funds |
| ATARA BIOTHERAPEUTICS INC. | June 10, 2024 | To approve the Company's 2024 Equity Incentive Plan Compensation |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| ATLASSIAN CORP. | December 6, 2023 | An advisory vote to approve the fiscal year 2023 compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 6 funds |
| AVANTAX INC | November 21, 2023 | Proposal to approve, by a non-binding advisory vote, the compensation that may be paid or become payable to Avantax, Inc.'s named executive officers that is based on, or otherwise relates to, the merger of C2023 Sub Corp. with and into Avantax, Inc., as contemplated by the merger agreement. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 7 funds |
| AXOGEN INC. | June 5, 2024 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| AXON ENTERPRISE INC. | May 10, 2024 | Proposal No. 2 requests that shareholders vote to approve the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan. Compensation |
Board | For | FOR 11 funds |
AGAINST 3 funds |
| BANDWIDTH INC. | May 23, 2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement; and Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| BEYOND INC. | May 21, 2024 | The approval of the grant of a performance-based stock option to Marcus A. Lemonis, the Company's Executive Chairman. Compensation |
Board | For | AGAINST 8 funds |
FOR 4 funds |
| BIOCRYST PHARMACEUTICALS INC. | June 12, 2024 | To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan by 7,000,000 shares. Compensation |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| BIONTECH SE | May 17, 2024 | Resolution on the approval of the compensation report Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| BRIGHTVIEW HOLDINGS INC. | March 5, 2024 | To approve the amendment to the BrightView Holdings, Inc. Amended and Restated 2018 Omnibus Incentive Plan. Compensation |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| CANNAE HOLDINGS INC. | June 19, 2024 | Approval of the redomestication of the Company from the State of Delaware to the State of Nevada by conversion. Extraordinary Transactions |
Board | For | FOR 7 funds |
AGAINST 5 funds |
| CAPITOL FEDERAL FINANCIAL INC. | January 23, 2024 | Election of Directors: (for three-year terms) Morris J. Huey, II Director Elections |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| CAPRI HOLDINGS LTD. | October 25, 2023 | To approve, on an advisory (nonbinding) basis, the compensation that may be paid or become payable to Capri Holdings Limited's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement. Say-on-Pay |
Board | For | AGAINST 12 funds |
FOR 5 funds |
| CAPSTAR FINANCIAL HOLDINGS INC. | February 29, 2024 | To approve, on a non-binding, advisory basis, the merger-related named executive officer compensation that will or may be paid to CapStar Financial Holdings, Inc.'s named executive officers in connection with the transactions contemplated by the Merger Agreement. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 2 funds |
| CENTURY ALUMINUM CO. | June 3, 2024 | Proposal to approve, on an advisory basis, the compensation of the named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 3 funds |
| CHECK POINT SOFTWARE TECHNOLOGIES LTD. | August 3, 2023 | To ratify the appointment and compensation of Kost, Forer, Gabbay & Kasierer, a member of Ernst & Young Global, as our independent registered public accounting firm for 2023. Audit-related |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CHESAPEAKE ENERGY CORP. | June 18, 2024 | Approval of, by non-binding, advisory vote, certain compensation arrangements for Chesapeake's named executive officers in connection with the merger contemplated by the Merger Agreement. Say-on-Pay |
Board | For | FOR 13 funds |
AGAINST 18 funds |
| CIMPRESS PLC | December 14, 2023 | Advisory Vote on Executive Compensation Say-on-Pay |
Board | For | FOR 9 funds |
AGAINST 1 fund |
| COMPX INTERNATIONAL INC. | May 22, 2024 | Say-on-Pay, nonbinding advisory vote approving executive compensation Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CONSTELLIUM SE | May 2, 2024 | Delegation of competence to the Board to increase the number of shares issued in case of a capital increase, without preferential subscription rights, by way of a public offering other than within the meaning of article L411-2 1 of the French Monetary and Financial Code, in accordance with article L225-135-1 of the French Commercial Code, by up to 15%, for a 15 month-period. Capital Structure |
Board | For | AGAINST 5 funds |
FOR 4 funds |
| CONSTRUCTION PARTNERS INC | March 20, 2024 | Proposal to approve the adoption of the Construction Partners, Inc. 2024 Restricted Stock Plan Compensation |
Board | For | AGAINST 7 funds |
FOR 3 funds |
| CORSAIR GAMING INC. | June 6, 2024 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers, or a Say-on-Pay vote. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 3 funds |
| COSTAMARE INC. | October 3, 2023 | Election of Class I Director to hold office for a three-year term expiring at the 2026 annual meeting: Konstantinos Zacharatos Director Elections |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CRISPR THERAPEUTICS AG | May 30, 2024 | Approval of amendments to the Articles of Association to facilitate the use of equity compensation and pension benefits programs consistent with current market practices. Compensation |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CRISPR THERAPEUTICS AG | May 30, 2024 | Approval of an increase of the conditional share capital for employee equity plans. Compensation |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| CUSTOM TRUCK ONE SOURCE INC. | June 13, 2024 | To amend the Custom Truck One Source, Inc. Amended and Restated 2019 Omnibus Incentive Plan to increase the number of shares available for the grant of awards from 14,650,000 shares to 20,650,000 shares. Compensation |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| DUN & BRADSTREET HOLDINGS INC. | June 12, 2024 | Approval of a non-binding advisory resolution on the compensation paid to our named executive officers. Say-on-Pay |
Board | For | FOR 13 funds |
AGAINST 4 funds |
| EASTMAN CHEMICAL CO. | May 2, 2024 | Advisory Approval of Executive Compensation as Disclosed in Proxy Statement Say-on-Pay |
Board | Not determined | FOR 15 funds |
AGAINST 15 funds |
| EMPIRE STATE REALTY TRUST INC. | May 9, 2024 | To approve the Empire State Realty Trust, Inc. Empire State Realty OP, L.P. 2024 Equity Incentive Plan. Compensation |
Board | For | FOR 11 funds |
AGAINST 6 funds |
| EVERCORE INC. | June 18, 2024 | Approval of the Third Amended and Restated 2016 Evercore Inc. Stock Incentive Plan. Compensation |
Board | For | AGAINST 10 funds |
FOR 9 funds |
| EXTREME NETWORKS INC. | November 8, 2023 | Approve an amendment and restatement of the Extreme Networks, Inc. 2013 Equity Incentive plan to, among other things, add 5,000,000 shares of our common stock to those reserved for issuance under the plan; and Compensation |
Board | For | AGAINST 5 funds |
FOR 5 funds |
| FATE THERAPEUTICS INC. | June 7, 2024 | To approve the amendment and restatement of the Company's 2022 Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder. Compensation |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| FATE THERAPEUTICS INC. | June 7, 2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 4 funds |
| FIDELITY NATIONAL FINANCIAL INC. | June 12, 2024 | Approval of the redomestication of the Company from the State of Delaware to the State of Nevada by conversion. Extraordinary Transactions |
Board | For | FOR 13 funds |
AGAINST 6 funds |
| FIRST WESTERN FINANCIAL INC. | June 5, 2024 | Advisory, non-binding vote to approve the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| FONAR CORP. | May 20, 2024 | On an advisory basis, to recommend the frequency of the advisory vote on Executive Compensation. Say-on-Pay |
Board | For | ABSTAIN 2 funds |
FOR 1 fund |
| FRANKLIN BSP REALTY TRUST INC. | May 29, 2024 | ADVISORY VOTE ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 2 funds |
| GLAUKOS CORP. | May 30, 2024 | Approval of the Glaukos Corporation Amended and Restated 2015 Omnibus Incentive Compensation Plan. Compensation |
Board | For | FOR 4 funds |
AGAINST 2 funds |
| GLOBAL-E ONLINE LTD. | June 20, 2024 | To approve the re-appointment of Kost, Forer, Gabbay & Kasierer, registered public accounting firm, a member of Ernst & Young Global, as the Company's independent registered public accounting firm for the year ending December 31, 2024 and until the next annual general meeting of shareholders, and to authorize the Company's board of directors (with power of delegation to its audit committee) to set the fees to be paid to such auditors. Audit-related |
Board | For | FOR 1 fund |
AGAINST 3 funds |
| HAYNES INTERNATIONAL INC. | April 16, 2024 | To approve, on an advisory, non-binding, basis, the compensation that may be paid or become payable to Haynes' named executive officers in connection with the transactions contemplated by the Merger Agreement. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 3 funds |
| HEIDRICK & STRUGGLES INTERNATIONAL INC. | May 23, 2024 | Approval of the Fifth Amended and Restated Heidrick & Struggles 2012 GlobalShare Program. Compensation |
Board | For | AGAINST 7 funds |
FOR 2 funds |
| HERON THERAPEUTICS INC. | June 13, 2024 | To approve, on a nonbinding advisory basis, compensation paid to our Named Executive Officers during the fiscal year ended December 31, 2023. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 2 funds |
| HESS CORP. | May 28, 2024 | To adopt the Agreement and Plan of Merger, dated as of October 22, 2023 (as may be amended from time to time, the "merger agreement"), by and among Chevron Corporation, Yankee Merger Sub Inc. and Hess Corporation ("Hess"). Extraordinary Transactions |
Board | For | FOR 14 funds |
ABSTAIN 5 funds |
| HESS CORP. | May 28, 2024 | To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to Hess' named executive officers that is based on or otherwise related to the merger. Say-on-Pay |
Board | For | FOR 15 funds |
AGAINST 7 funds |
| INMODE LTD. | April 1, 2024 | To elect Mr. Nadav Kenneth to serve as a Class II director of the Company, and to hold office until the annual general meeting of shareholders to be held in 2027 and until his successor is duly elect- ed and qualified, or until his earlier resignation or retirement. Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| INMODE LTD. | April 1, 2024 | To re-elect Dr. Michael Anghel to serve as a Class II director of the Company, and to hold office until the annual general meeting of shareholders to be held in 2027 and until his successor is duly elect- ed and qualified, or until his earlier resignation or retirement. Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| INTERNATIONAL GAME TECHNOLOGY PLC | May 14, 2024 | To approve the Directors' Remuneration Policy. Other |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| INTUITIVE SURGICAL INC. | April 25, 2024 | The amendment and restatement of the Amended and Restated 2010 Incentive Award Plan. Compensation |
Board | For | AGAINST 15 funds |
FOR 21 funds |
| INVESCO LTD. | May 23, 2024 | Amendment and restatement of the Invesco Ltd. 2016 Global Equity Incentive Plan to increase the number of authorized shares and make certain other revisions Compensation |
Board | For | FOR 14 funds |
AGAINST 5 funds |
| IQVIA HOLDINGS INC. | April 16, 2024 | Approve an advisory (non-binding) resolution to approve IQVIA's executive compensation (say-on-pay). Say-on-Pay |
Board | For | FOR 18 funds |
AGAINST 11 funds |
| IROBOT CORP. | October 12, 2023 | To approve, on an advisory (non-binding) basis, certain compensation that may be paid or become payable to iRobot's named executive officers in connection with the merger; and Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 3 funds |
| IROBOT CORP. | May 23, 2024 | Approve an amendment to the iRobot Corporation 2018 Stock Option and Incentive Plan, as amended (the "2018 Plan"), to increase the maximum number of shares reserved and issuable under the 2018 Plan. Compensation |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| KANZHUN LIMITED | June 28, 2024 | To re-elect Mr. Peng Zhao as an executive Director. Director Elections |
Board | For | AGAINST 2 funds |
FOR 4 funds |
| KARUNA THERAPEUTICS INC. | March 12, 2024 | To approve, on an advisory, non-binding basis, certain compensation that will or may be paid by Karuna to its named executive officers that is based on or otherwise relates to the merger of Merger Sub with and into Karuna pursuant to the merger agreement. Say-on-Pay |
Board | For | AGAINST 12 funds |
FOR 4 funds |
| KE HOLDINGS INC. | June 14, 2024 | As an ordinary resolution, to re-elect Mr. Jun Wu as an independent nonexecutive Director. Director Elections |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| KE HOLDINGS INC. | June 14, 2024 | As an ordinary resolution, to re-elect Mr. Yigang Shan as an executive Director. Director Elections |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| KLX ENERGY SERVICES HOLDINGS INC. | May 9, 2024 | To approve, on an advisory, non-binding basis, the compensation of the Company's named executive officers; Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| KURA ONCOLOGY INC. | June 5, 2024 | Approval, on an advisory basis, of the compensation of our named executive officers during the year ended December 31, 2023. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 5 funds |
| LEMONADE INC. | June 5, 2024 | To approve on an advisory (non-binding) basis the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 4 funds |
| LINCOLN NATIONAL CORP. | May 23, 2024 | The approval of an amendment to the Lincoln National Corporation 2020 Incentive Compensation Plan. Compensation |
Board | For | FOR 12 funds |
AGAINST 2 funds |
| MACROGENICS INC. | May 21, 2024 | To approve the amendment to the MacroGenics, Inc. 2023 Equity Incentive Plan, as disclosed in the proxy materials. Compensation |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| MAGELLAN MIDSTREAM PARTNERS LP | September 21, 2023 | To approve, on a non-binding advisory basis, the compensation that may be paid or become payable to the named executive officers of Magellan GP, LLC, the general partner of Magellan, that is based on or otherwise relates to the merger contemplated by the Merger Agreement. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| MARCUS & MILLICHAP INC. | May 2, 2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 4 funds |
| MICROCHIP TECHNOLOGY INC. | August 22, 2023 | Proposal to approve an amendment and restatement of our 1994 International Employee Stock Purchase Plan to extend the term of the Plan by ten years to November 30, 2034. Compensation |
Board | For | AGAINST 14 funds |
FOR 8 funds |
| MICROCHIP TECHNOLOGY INC. | August 22, 2023 | Proposal to approve an amendment and restatement of our 2001 Employee Stock Purchase Plan to extend the term of the Plan by ten years to August 31, 2034. Compensation |
Board | For | AGAINST 14 funds |
FOR 8 funds |
| MOELIS & CO. | June 6, 2024 | 2024 Moelis Omnibus Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 7 funds |
| MUELLER INDUSTRIES INC. | September 26, 2023 | Approve the amendment to the Company's Restated Certificate of Incorporation to increase the number of authorized shares of common stock by 150,000,000 shares. Capital Structure |
Board | For | AGAINST 8 funds |
FOR 9 funds |
| MULTIPLAN CORP. | April 24, 2024 | Approval of the Amendment to the MultiPlan Corporation 2020 Omnibus Incentive Plan. Compensation |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| NECESSITY RETAIL REIT INC (THE) | September 8, 2023 | To approve, by advisory (non-binding) vote, certain compensation arrangements for RTL's named executive officers in connection with the Proposed Transactions discussed under the section titled "The Companies - The Combined Company - Potential Conflicts of Interest of Officers and Directors of GNL and RTL" beginning on page 50. Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 4 funds |
| NECESSITY RETAIL REIT INC. | September 8, 2023 | To approve the merger of RTL and GNL, which will be effected through a merger of RTL with and into Osmosis Sub I, LLC ("REIT Merger Sub"), a wholly owned subsidiary of GNL. Extraordinary Transactions |
Board | For | AGAINST 9 funds |
FOR 2 funds |
| NEOGENOMICS INC. | May 23, 2024 | Approval, on an advisory basis, of the Compensation Paid to the Company's Named Executive Officers. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 7 funds |
| NEUMORA THERAPEUTICS INC. | June 13, 2024 | To elect two Class I directors to hold office until the 2027 annual meeting of stockholders or until their successors are elected: Henry O. Gosebruch Director Elections |
Board | For | WITHHOLD 4 funds |
FOR 1 fund |
| NEW YORK COMMUNITY BANCORP INC. | June 5, 2024 | Approval of proposed amendments to the New York Community Bancorp, Inc. 2020 Omnibus Incentive Plan. Compensation |
Board | For | FOR 12 funds |
AGAINST 4 funds |
| NIKOLA CORP. | August 3, 2023 | The approval of an amendment to the Nikola Corporation 2020 Stock Incentive Plan to increase the number of shares of common stock available for issuance thereunder by 30,000,000 shares, which is contingent on the approval of Proposal 2. Compensation |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| NORFOLK SOUTHERN CORP. | May 9, 2024 | Approval of the advisory resolution on executive compensation, as disclosed in the Norfolk Southern's proxy statement for the 2024 Annual Meeting. Say-on-Pay |
Board | Contested | AGAINST 14 funds |
ABSTAIN 1 fund |
| NOVAVAX INC. | June 13, 2024 | Amendment and restatement of the Novavax, Inc. Amended and Restated 2013 Employee Stock Purchase Plan to increase the number of shares of common stock available for issuance thereunder by 1,000,000 shares, such that the number of shares available for issuance thereunder is the lesser of (a) 2,155,000 shares of common stock increased on January 1 of each year by 5% of the share pool on such January 1 (rounded down to the nearest whole share) and (b) 3,510,264 shares of common stock. Compensation |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| NU HOLDINGS LTD. | August 16, 2023 | To resolve, as an ordinary resolution, that the reelection of the individuals listed from "a" to "i", as directors of the Company (the "Nominees"), each to serve for a term ending on the date of the next annual general meeting of the Members, or until such person resigns or is removed in accordance with the terms of the Memorandum and Articles of Association of the Company, be approved: David Velez Osorno; Director Elections |
Board | For | AGAINST 3 funds |
FOR 4 funds |
| NURIX THERAPEUTICS INC. | May 20, 2024 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| OPENDOOR TECHNOLOGIES INC. | June 14, 2024 | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers (Say-on-Pay Vote). Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 5 funds |
| OPTIMIZERX CORP. | June 5, 2024 | Amendment to OptimizeRx Corporation 2021 Equity Incentive Plan to increase the aggregate number of shares of common stock available for awards by 1,950,000 shares to 4,450,000 shares. Compensation |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| ORACLE CORP. | November 15, 2023 | Approve an Amendment to the Oracle Corporation Amended and Restated 2020 Equity Incentive Plan Compensation |
Board | For | AGAINST 13 funds |
FOR 33 funds |
| ORMAT TECHNOLOGIES INC. | May 8, 2024 | To approve an amendment and restatement of the Company's 2018 Incentive Compensation Plan to increase the total number of shares reserved thereunder. Compensation |
Board | For | AGAINST 9 funds |
FOR 1 fund |
| OUTSET MEDICAL INC. | May 29, 2024 | Advisory vote to approve 2023 named executive officer compensation Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 5 funds |
| PAR TECHNOLOGY CORP. | June 3, 2024 | Approval of an Amendment to the Amended and Restated PAR Technology Corporation 2015 Equity Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 1,900,000 shares. Compensation |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| PGT INNOVATIONS INC. | March 18, 2024 | To approve on an advisory (non-binding) basis the compensation that may be paid or become payable to PGTI's named executive officers that is based on or otherwise relates to the merger (referred to as the "merger-related compensation proposal"); Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 4 funds |
| QIAGEN NV | June 21, 2024 | Proposal to adopt the Remuneration Policy with respect to the Supervisory Board. Compensation |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| QIAGEN NV | June 21, 2024 | Proposal to authorize the Supervisory Board, until December 21, 2025 to: issue a number of ordinary shares and financing preference shares and grant rights to subscribe for such shares of up to 50% of the aggregate par value of all shares issued and outstanding. Capital Structure |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| QIAGEN NV | June 21, 2024 | Proposal to determine the remuneration of the members of the Supervisory Board. Compensation |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| QIAGEN NV | June 21, 2024 | Reappointment of the Supervisory Director: Mr. Lawrence A. Rosen Director Elections |
Board | For | AGAINST 2 funds |
FOR 1 fund |
Page 1 of 3 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.